Yuan‐Chuan Chen

884 total citations
40 papers, 565 citations indexed

About

Yuan‐Chuan Chen is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Yuan‐Chuan Chen has authored 40 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Epidemiology and 11 papers in Infectious Diseases. Recurrent topics in Yuan‐Chuan Chen's work include Cytomegalovirus and herpesvirus research (10 papers), RNA Interference and Gene Delivery (9 papers) and Herpesvirus Infections and Treatments (7 papers). Yuan‐Chuan Chen is often cited by papers focused on Cytomegalovirus and herpesvirus research (10 papers), RNA Interference and Gene Delivery (9 papers) and Herpesvirus Infections and Treatments (7 papers). Yuan‐Chuan Chen collaborates with scholars based in United States, Taiwan and China. Yuan‐Chuan Chen's co-authors include Shao-Cheng Wang, Shiu‐Jau Chen, Fenyong Liu, Phong Trang, Shaw-Ji Chen, Hao Gong, Ming‐Kung Yeh, Sangwei Lu, Gia-Phong Vu and Hwei‐Fang Cheng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yuan‐Chuan Chen

39 papers receiving 555 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuan‐Chuan Chen United States 13 241 196 66 57 53 40 565
Hongli Zhou China 19 337 1.4× 150 0.8× 120 1.8× 92 1.6× 44 0.8× 41 831
Hung Chan China 10 280 1.2× 137 0.7× 58 0.9× 72 1.3× 25 0.5× 19 533
Marta Popiel Poland 9 145 0.6× 152 0.8× 97 1.5× 45 0.8× 73 1.4× 14 605
L. Persson Sweden 12 109 0.5× 237 1.2× 108 1.6× 44 0.8× 63 1.2× 16 498
Paul Mark B. Medina Philippines 16 166 0.7× 103 0.5× 103 1.6× 62 1.1× 45 0.8× 49 598
Lijuan Shen China 15 222 0.9× 66 0.3× 76 1.2× 97 1.7× 90 1.7× 75 666
Chang‐Huei Tsao Taiwan 18 225 0.9× 132 0.7× 108 1.6× 50 0.9× 199 3.8× 54 884
Jing Kong China 16 278 1.2× 82 0.4× 126 1.9× 155 2.7× 62 1.2× 49 794
Shuhua Ma China 19 400 1.7× 99 0.5× 52 0.8× 161 2.8× 42 0.8× 67 1.1k
Boris Lamp Germany 8 392 1.6× 129 0.7× 118 1.8× 109 1.9× 33 0.6× 9 714

Countries citing papers authored by Yuan‐Chuan Chen

Since Specialization
Citations

This map shows the geographic impact of Yuan‐Chuan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan‐Chuan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan‐Chuan Chen more than expected).

Fields of papers citing papers by Yuan‐Chuan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuan‐Chuan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan‐Chuan Chen. The network helps show where Yuan‐Chuan Chen may publish in the future.

Co-authorship network of co-authors of Yuan‐Chuan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yuan‐Chuan Chen. A scholar is included among the top collaborators of Yuan‐Chuan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuan‐Chuan Chen. Yuan‐Chuan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Shiu‐Jau, et al.. (2025). Infection and Prevention of Rabies Viruses. Microorganisms. 13(2). 380–380. 2 indexed citations
2.
Chen, Yuan‐Chuan, et al.. (2024). Novel Administration Routes, Delivery Vectors, and Application of Vaccines Based on Biotechnologies: A Review. Vaccines. 12(9). 1002–1002. 5 indexed citations
3.
Chen, Shiu‐Jau, et al.. (2023). Point-of-Care Testing for Infectious Diseases Based on Class 2 CRISPR/Cas Technology. Diagnostics. 13(13). 2255–2255. 13 indexed citations
4.
Yan, Bin, et al.. (2023). RNase P Ribozyme Effectively Inhibits Human CC-Chemokine Receptor 5 Expression and Human Immunodeficiency Virus 1 Infection. SHILAP Revista de lepidopterología. 3(2). 93–103. 2 indexed citations
5.
Yan, Bin, Yujun Liu, Yuan‐Chuan Chen, & Fenyong Liu. (2023). A RNase P Ribozyme Inhibits Gene Expression and Replication of Hepatitis B Virus in Cultured Cells. Microorganisms. 11(3). 654–654. 5 indexed citations
6.
Liu, Yujun, Yuan‐Chuan Chen, Bin Yan, & Fenyong Liu. (2023). Suppressing Kaposi’s Sarcoma-Associated Herpesvirus Lytic Gene Expression and Replication by RNase P Ribozyme. Molecules. 28(8). 3619–3619. 4 indexed citations
8.
Chen, Shiu‐Jau, Shao-Cheng Wang, & Yuan‐Chuan Chen. (2021). The Immunotherapy for Colorectal Cancer, Lung Cancer and Pancreatic Cancer. International Journal of Molecular Sciences. 22(23). 12836–12836. 25 indexed citations
9.
Chen, Yuan‐Chuan. (2021). CRISPR based genome editing and removal of human viruses. Progress in molecular biology and translational science. 179. 93–116. 3 indexed citations
10.
Wang, Shao-Cheng, et al.. (2020). Alcohol Addiction, Gut Microbiota, and Alcoholism Treatment: A Review. International Journal of Molecular Sciences. 21(17). 6413–6413. 95 indexed citations
11.
Chen, Shiu‐Jau, Shao-Cheng Wang, & Yuan‐Chuan Chen. (2020). Novel Antiviral Strategies in the Treatment of COVID-19: A Review. Microorganisms. 8(9). 1259–1259. 16 indexed citations
12.
Wang, Shao-Cheng, Shiu‐Jau Chen, & Yuan‐Chuan Chen. (2020). Potential Therapeutic Approaches Against Brain Diseases Associated with Cytomegalovirus Infections. International Journal of Molecular Sciences. 21(4). 1376–1376. 1 indexed citations
13.
Chen, Shiu‐Jau & Yuan‐Chuan Chen. (2019). Potential Application of TALENs against Murine Cytomegalovirus Latent Infections. Viruses. 11(5). 414–414. 10 indexed citations
14.
Chen, Shiu‐Jau, Shao-Cheng Wang, & Yuan‐Chuan Chen. (2019). Antiviral Agents as Therapeutic Strategies Against Cytomegalovirus Infections. Viruses. 12(1). 21–21. 37 indexed citations
15.
Zhang, Zhigang, Gia-Phong Vu, Hao Gong, et al.. (2013). Engineered External Guide Sequences Are Highly Effective in Inhibiting Gene Expression and Replication of Hepatitis B Virus in Cultured Cells. PLoS ONE. 8(6). e65268–e65268. 10 indexed citations
16.
Xia, Chuan, Yuan‐Chuan Chen, Hao Gong, et al.. (2013). Inhibition of Hepatitis B Virus Gene Expression and Replication by Ribonuclease P. Molecular Therapy. 21(5). 995–1003. 25 indexed citations
17.
Chen, Yuan‐Chuan, Xihan Li, Ke Zen, et al.. (2013). Detection of the pandemic H1N1/2009 influenza A virus by a highly sensitive quantitative real-time reverse-transcription polymerase chain reaction assay. Virologica Sinica. 28(1). 24–35. 4 indexed citations
18.
Jiang, Xiaohong, Yuan‐Chuan Chen, Hao Gong, et al.. (2012). Ribonuclease P-mediated inhibition of human cytomegalovirus gene expression and replication induced by engineered external guide sequences. RNA Biology. 9(9). 1186–1195. 8 indexed citations
19.
Pei, Yonggang, Ao Shen, Yuan‐Chuan Chen, et al.. (2012). A Hsp40 Chaperone Protein Interacts with and Modulates the Cellular Distribution of the Primase Protein of Human Cytomegalovirus. PLoS Pathogens. 8(11). e1002968–e1002968. 30 indexed citations
20.
Zeng, Wenbo, Yuan‐Chuan Chen, Yong Bai, et al.. (2012). Effective Inhibition of Human Immunodeficiency Virus 1 Replication by Engineered RNase P Ribozyme. PLoS ONE. 7(12). e51855–e51855. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026